 |
2016-01-27 16:45:27 Have you got any ●●●●●●●●●●●●ns? ●●●●●●y ●●●●●●co ●●●●●● For the Call to Action to ●●●●●●d it must be built from the local ●●●●●●s. CCGs are small, lean ●●●●●●●●●●●●s with ●●●●●●d ●●●●●●ty to take ●●●●●●ake new ●●●●●●ours. We must make this work, but it must also be ●●●●●●ised that to ●●●●●●se what ●●●●●● be a ●●●●●●e ●●●●●● ●●●●●●ment ●●●●●●se takes time and ●●●●●●ces and so we would ●●●●●●on ●●●●●●r it would be ●●●●●●le to ●●●●●●p ●●●●●●tic ●●●●●●ons in time for 2014. CCGs will help lead the ●●●●●●●●●●●●, but today is just the start of a ●●●●●●ue which will need to ●●●●●●ue for ●●●●●●me. ●●●●●● ngyn The Israel-based ●●●●●●y said the U.S. Food and DrugA●●●●●●●●●●●●n ●●●●●● its ●●●●●●al hold on a mid-stage trial ofthe ●●●●●●y's ●●●●●●●●●●●● drug for ●●●●●● pain. P●●●●●●em ●●●●●●e FDA ●●●●●●d it to go ahead with the study, ●●●●●● thatP●●●●●●em had ●●●●●●sed all ●●●●●● ●●●●●●d to the hold. |